Bank of New York Mellon Corp
BankPosition in TBPH — Theravance Biopharma, Inc.
CIK 1390777
NEW YORK, NY
Position in TBPH
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,851,306
-$366,707 QoQ
Shares Held
114,067
-3.8% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,077,029,278 across 270 Biotechnology names. TBPH ranks #124 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in TBPH
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,851,306 | 114,067 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,218,013 | 118,547 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,672,721 | 114,570 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,219,321 | 110,546 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,049,264 | 117,499 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,089,479 | 115,779 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $975,750 | 121,061 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,280,242 | 150,972 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,453,390 | 162,028 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $2,207,355 | 196,384 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,754,591 | 203,313 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,237,182 | 216,153 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,278,650 | 210,014 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,374,106 | 211,596 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,083,465 | 205,470 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,648,149 | 181,915 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,813,502 | 189,697 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,081,001 | 188,326 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,305,515 | 176,421 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,546,211 | 175,359 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,129,125 | 202,309 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $3,119,264 | 210,975 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,519,461 | 215,315 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,875,469 | 210,968 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||